REVENUE MEMORANDUM CIRCULAR NO. 121-2022 issued on August 22, 2022 prescribes the guidelines on the lifting of suspension of field audit and operations on all outstanding Letters of Authority/Audit Notices, and Letter Notices pursuant to Revenue

REVENUE MEMORANDUM CIRCULAR NO. 120-2022 issued on August 18, 2022 prescribes additional guidelines and procedures on the manner of payment of penalty relative to violations incurred by Registered Business Enterprises (RBEs) in the Information Technology-Business Process

REVENUE MEMORANDUM CIRCULAR NO. 119-2022 issued on August 8, 2022 publishes the July 20, 2022 letter from Food and Drug Administration (FDA) OIC-Director General Oscar G. Gutierrez, Jr. endorsing updates to the “List of VAT-Exempt Medicines”

REVENUE MEMORANDUM CIRCULAR NO. 118-2022 issued on August 8, 2022 publishes the full text of Republic Act (RA) No. 11900 titled “An Act Regulating the Importation, Manufacture, Sale, Packaging, Distribution, Use, and Communication of Vaporized

REVENUE MEMORANDUM CIRCULAR NO. 117-2022 issued on August 8, 2022 publishes the full text of Memorandum Circular (MC) No. 3, series of 2022, titled “Amending and Supplementing Memorandum Circular No. 1, series of 2022 by

REVENUE MEMORANDUM CIRCULAR NO. 116-2022 issued on August 4, 2022 publishes the July 11, 2022 letter from Food and Drug Administration (FDA) OIC-Director General Oscar G. Gutierrez, Jr. endorsing updates to the “List of VAT-Exempt Medicines”

REVENUE MEMORANDUM CIRCULAR NO. 115-2022 issued on July 28, 2022 lifts the suspension on the issuance of Mission Orders insofar as authorizing Revenue Officers to conduct Tax Compliance Verification Drive (TCVD). This includes verification of

REVENUE MEMORANDUM CIRCULAR NO. 114-2022 issued on July 28, 2022 prescribes the guidelines on the registration of Department of Education (DepEd), Regional Offices, Division Offices and Implementing Unit Schools.            Pending the

REVENUE MEMORANDUM CIRCULAR NO. 113-2022 issued on July 28, 2022 publishes the July 1, 2022 letter from Food and Drug Administration OIC-Director General Oscar G. Gutierrez, Jr. endorsing updates to the “List of VAT-Exempt Medicines”

REVENUE MEMORANDUM CIRCULAR NO. 112-2022 issued on July 28, 2022 publishes the June 27, 2022 letter from Food and Drug Administration OIC-Director General Oscar G. Gutierrez, Jr. endorsing updates to the “List of VAT-Exempt Medicines”